2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

about

Coding Microsatellite Frameshift Mutations Accumulate in Atherosclerotic Carotid Artery Lesions: Evaluation of 26 Cases and Literature Review.Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall.

P2860

Q36167056-9CB16C49-C3B1-456E-BC69-0F301602022B Q38930482-D1E696F2-A367-4D89-97DC-D3250BAB4C76

P2860

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

Item

http://www.wikidata.org/entity/Q43007212

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

@en

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

@nl

type

Item

label

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

@en

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

@nl

prefLabel

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

@en

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

@nl

P1476

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

@en

P2093

Harry C Dietz

http://www.w3.org/2001/XMLSchema#string

P2860

Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein

Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1

Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

Aneurysm syndromes caused by mutations in the TGF-beta receptor

Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome

Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3)

Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome

P304

662-667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/521409

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44655405

http://www.w3.org/2001/XMLSchema#string

P698

20529617

http://www.w3.org/2001/XMLSchema#string

P932

2227916

http://www.w3.org/2001/XMLSchema#string

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

about

P2860

P2860

2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932